Replies to post #1062 on Statera BioPharma Inc (STAB)

[goforthebet]

Building on our growth strategy are the assets we will acquire from Cleveland BioLabs, as well as the drug development tools and services obtained with the acquisition of ImQuest Life Sciences. These two transactions represent a transformative growth opportunity, not only for Cytocom, but also for the shareholders of both Cleveland BioLabs and ImQuest Life Sciences.

that sounds very good.

imo a buy and hold for the next 5 years